Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humanis is a prominent Turkish pharmaceutical company that specializes in the development, manufacturing, and marketing of high-quality generic medications and consumer healthcare products. Formerly known as Pharmactive İlaç, the company operates a state-of-the-art, EU-GMP certified manufacturing facility in Çerkezköy with a significant production capacity for various dosage forms including solids, liquids, and semi-solids. Humanis is heavily invested in research and development, maintaining a dedicated R&D center that focuses on developing value-added generics and biosimilars. The company serves as a strategic CDMO partner for several multinational pharmaceutical firms and exports its products to numerous countries across Europe, Asia, and Africa. Rebranded in 2023, Humanis aims to provide accessible healthcare solutions with a human-centric approach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humanis Sağlık.